JOINN(06127)

13.860-0.640-4.41%

CommunityCommunity
NewsNews
ProfileProfile
AnnouncementsAnnouncements

- Joinn Laboratories (China) Warns of Up to 85% Profit Slump in 2024
  MT Newswires Live · 01-27
  Joinn Laboratories (China) Warns of Up to 85% Profit Slump in 2024
- Joinn Laboratories to Provide Pharmaceutical Research, Development Services to Staidson
  MT Newswires Live · 2024-12-23
  Joinn Laboratories to Provide Pharmaceutical Research, Development Services to Staidson
- Joinn Laboratories' Q3 Profit Slides 58%
  MT Newswires Live · 2024-11-01
  Joinn Laboratories' Q3 Profit Slides 58%
Company Profile
Company Name
JOINN
Market
SEHK
Establishment Date
1995
Employees
2510
Office Location
A5 Rongjing East Street,Beijing Eco-Techno Development Area,Beijing,China
Website
- -
Zip Code
100176
Phone
86 10 6786 9582
Fax
86 10 6786 9966
Introduction
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.
Industry
Life Sciences Tools & Services
IPO Information
Listing Date
2021-02-25
Issue Price
151

1D
5D
Day
Week
Month

High

14.360

Open

14.160

Volume%

1.74

Low

13.180

Close

14.500

T/O Rate

3.63%

抱歉，当前请求异常(-1)

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"pagemeta":{"title":"JOINN(06127),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest JOINN(06127) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"JOINN,06127,JOINN股票,JOINN股票老虎,JOINN股票老虎国际,JOINN行情,JOINN股票行情,JOINN股价,JOINN股市,JOINN股票价格,JOINN股票交易,JOINN股票购买,JOINN股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"JOINN(06127),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest JOINN(06127) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}},"tab":"news","symbol":"06127","data":{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"JOINN","latestPrice":13.86,"timestamp":1743408510034,"preClose":14.5,"halted":0,"volume":4320070,"delay":0,"floatShares":119000000,"shares":749000000,"eps":0.5675196060125105,"marketStatus":"Not Yet Opened","change":-0.64,"latestTime":"03-31 16:08:30","open":14.16,"high":14.36,"low":13.18,"amount":59889345,"amplitude":0.081379,"askPrice":13.86,"askSize":28700,"bidPrice":13.82,"bidSize":3700,"shortable":0,"etf":0,"ttmEps":-0.0012581802586126413,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1743471000000},"marketStatusCode":0,"adr":0,"listingDate":1614268800000,"exchange":"SEHK","adjPreClose":14.5,"dividendRate":0.01236,"openAndCloseTimeList":[[1743384600000,1743393600000],[1743397200000,1743408000000]],"volumeRatio":1.7369007839089394,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"Joinn Laboratories (China) Co.,Ltd.","latestPrice":20.34,"timestamp":1743404400000,"preClose":21.24,"halted":0,"volume":11282700,"delay":0,"premium":"-36.36"}},"tweetData":null,"newsData":{"listData":[{"id":"2506376683","title":"Joinn Laboratories (China) Warns of Up to 85% Profit Slump in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2506376683","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506376683?lang=en_us&edition=full_marsco","pubTime":"2025-01-27 20:07","pubTimestamp":1737979647,"startTime":"0","endTime":"0","summary":"Joinn Laboratories   expects a net profit attributable to shareholders of around 58.7 million yuan and 88.0 million yuan for 2024, representing a between 77.8% to 85.2% year-over-year decline.The drug developer attributed the forecast to lower gross profit margins and the decrease in the market price of biological assets held by the company, a Friday Hong Kong bourse filing said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0216","603127","06127","BK1576","BK1141"],"gpt_icon":0},{"id":"2493534447","title":"Joinn Laboratories to Provide Pharmaceutical Research, Development Services to Staidson","url":"https://stock-news.laohu8.com/highlight/detail?id=2493534447","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493534447?lang=en_us&edition=full_marsco","pubTime":"2024-12-23 19:28","pubTimestamp":1734953302,"startTime":"0","endTime":"0","summary":"Joinn Laboratories   agreed to provide certain services to Staidson  Biopharmaceuticals  group for 2025, a Friday Hong Kong bourse filing said.Under the agreement, the company will provide professional and technical services and a comprehensive range of pharmaceutical research and development services to the Staidson Group.The proposed annual cap for the services agreement is 50 million yuan.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1576","300204","BK0046","BK0239","603127","BK0216","06127","BK0028","BK1141"],"gpt_icon":0},{"id":"2480021664","title":"Joinn Laboratories' Q3 Profit Slides 58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480021664","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480021664?lang=en_us&edition=full_marsco","pubTime":"2024-11-01 14:42","pubTimestamp":1730443372,"startTime":"0","endTime":"0","summary":"Joinn Laboratories'  attributable profit fell 58% year over year to 99.4 million yuan in the third quarter, according to a Wednesday filing with the Hong Kong Exchange.Earnings per share at the pharmacology and toxicology research company decreased 59% year over year to 0.13 yuan.Operating income declined 16% year over year to 485.8 million yuan.Shares fell 1% during Friday's trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0216","BK1576","BK1141","603127","06127"],"gpt_icon":0}],"currentPage":1,"bottom":true},"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":{"stockEarnings":[{"period":"1week","weight":-0.1261},{"period":"1month","weight":0.0484},{"period":"3month","weight":0.4824},{"period":"6month","weight":0.1907},{"period":"1year","weight":0.5476},{"period":"ytd","weight":0.4824}],"compareEarnings":[{"period":"1week","weight":-0.0329},{"period":"1month","weight":0.0078},{"period":"3month","weight":0.1525},{"period":"6month","weight":0.0301},{"period":"1year","weight":0.3977},{"period":"ytd","weight":0.1525}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.111191},{"month":2,"riseRate":0.75,"avgChangeRate":0.13794},{"month":3,"riseRate":0.4,"avgChangeRate":-0.007631},{"month":4,"riseRate":0.25,"avgChangeRate":-0.064961},{"month":5,"riseRate":0.75,"avgChangeRate":0.028518},{"month":6,"riseRate":0.5,"avgChangeRate":0.026858},{"month":7,"riseRate":0.75,"avgChangeRate":0.036307},{"month":8,"riseRate":0,"avgChangeRate":-0.164063},{"month":9,"riseRate":0.5,"avgChangeRate":0.001124},{"month":10,"riseRate":0.25,"avgChangeRate":-0.061345},{"month":11,"riseRate":0.5,"avgChangeRate":0.080654},{"month":12,"riseRate":0.5,"avgChangeRate":-0.057443}],"exchange":"SEHK","name":"JOINN","nameEN":"JOINN"},"aProfile":null}}}